Validation and Evaluation of a Portable Body Scanner for Determination of Obesity

NCT ID: NCT01049269

Last Updated: 2015-06-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

180 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-31

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to validate a portable 3D human body measurement system which will improve approaches in obesity assessment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Obesity has become an epidemic in the United States. A new technique of three-dimensional (3 D) photonic scanning will be used to create and validate a portable instrument that rapidly assesses obesity in clinical and field settings. This new portable body scanner will be a safe and easy method to help determine the incidence and type of obesity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1:one group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-60 years old
* BMI between 18.50 to 39.99 kg/m3
* Free of known diseases
* Hispanic and Not Hispanic or Latino Whites

Exclusion Criteria

* Women who are pregnant, could be pregnant, or lactating
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

Sponsor Role collaborator

University of Texas at Austin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeanne H. Freeland-Graves, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

The University of Texas at Austin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Uniersity of Texas at Austin

Austin, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5R21DK081206

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01DK081206

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CoolSculpting the Upper Arm Study
NCT02669329 COMPLETED NA